VITAMIN D AND TISSULAR EXPRESSION OF VITAMIN D RECEPTOR IN OBESITY

Authors

  • Raluca HALIGA University of Medicine and Pharmacy “Grigore T. Popa”-Iasi
  • R. ZUGUN-ELOAE University of Medicine and Pharmacy “Grigore T. Popa”-Iasi
  • T. OBOROCEANU University of Medicine and Pharmacy “Grigore T. Popa”-Iasi
  • A. PINZARIU University of Medicine and Pharmacy “Grigore T. Popa”-Iasi
  • Veronica MOCANU University of Medicine and Pharmacy “Grigore T. Popa”-Iasi

Abstract

Vitamin D (VitD), a lipid-soluble hormone, is able to regulate the transcription of many genes through vitamin D receptor (vitD receptor - VDR). It has been shown that VitD deficiency is associated with obesity, characterized by a low degree inflammatory state, which contribute to the pathogeny of metabolic syndrome and type 2 diabetes mellitus. VitD deficiency is a public health problem, at the same time the global prevalence of obesity and cardiovascular diseases is continuously growing. Evidence from recent studies on animal models suggest that VitD or VDR deficiency promotes cardiomyocyte hypertrophy, which can be one of the mechanisms for increasing cardiovascular risk. The heart is one of the target organs of action for VitD, because VDR is expressed in cardiomyocytes. Also, previous in vitro studies have shown that VitD is able to inhibit the production of monocyte chemotactic factors (MCP-1) and other pro-inflammatory mediators in human preadipocytes and mature adipocytes. Inflammation is an important factor in the pathogenesis of atherosclerosis. In obesity there are not known data about correlations between plasma levels of VitD and VDR expression in the subcutaneous fat tissue, epicardial visceral adipose tissue, and in particular in myocardium. Also, there are still no studies to test VDR expression in myocardial cells and to investigate the results of dietary VitD supplementation on the expression of VDR in the epicardial adipose tissue and myocardium.

Author Biographies

  • Raluca HALIGA, University of Medicine and Pharmacy “Grigore T. Popa”-Iasi

    Faculty of Medicine
    Department of Morpho-functional Sciences

  • R. ZUGUN-ELOAE, University of Medicine and Pharmacy “Grigore T. Popa”-Iasi

    Faculty of Medicine
    Department of Morpho-functional Sciences

  • T. OBOROCEANU, University of Medicine and Pharmacy “Grigore T. Popa”-Iasi

    Faculty of Medicine
    Department of Morpho-functional Sciences

  • A. PINZARIU, University of Medicine and Pharmacy “Grigore T. Popa”-Iasi

    Faculty of Medicine
    Department of Morpho-functional Sciences

  • Veronica MOCANU, University of Medicine and Pharmacy “Grigore T. Popa”-Iasi

    Faculty of Medicine
    Department of Morpho-functional Sciences

References

1. Slusher AL., McAllister MJ., Huang Chun-Jung. A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention. Inflamm. Res. 2015; 64: 565–575.
2. Galesanu C., Mocanu V. Vitamin D deficiency and the clinical consequences Rev Med Chir Soc Med Nat Iasi. 2015; 119(2): 310-318.
3. Ryan K. JP, Zoe CTR D., Craggs LJL, et al. Dose-dependent effects of vitamin D on transdifferentia-tion of skeletal muscle cells to adipose cells. J Endocrino 2013; 217: 45–58
4. Dozio E., Briganti S., Vianello E., Dogliotti G., et al. Epicardial adipose tissue inflammation is related to vitamin D deficiency in patients affected by coronary artery disease. Nutrit, Metab & Cardiovasc Dis 2015; 25: 267-273
5. Vettor R., Milan G., Franzin C., Sanna,M., De Coppi P., Rizzuto R., Federspil, G. The origin of in-termuscular adipose tissue and its pathophysiological implications. Am. J. Physiol. 2009; 297: E987-E998
6. Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN. 1,25(OH)2 vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinol 2011; 152: 2976–2986.
7. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 2008; 29(6): 407-414.
8. Girgis C.M., Cha Kuan Minn, Houweling Peter J., et al. Vitamin D Receptor Ablation and Vitamin D Deficiency Result in Reduced Grip Strength, Altered Muscle Fibers, and Increased Myostatin in Mice. Calcified Tissue International 2015; DOI 10.1007/s00223-015-0054-x
9. Tagliafico AS, Ameri P, Bovio M, et al. Relationship between fatty degeneration of thigh muscles and vitamin D status in the elderly: a preliminary MRI study. AJR. A J of Roentgenol 2010; 194: 728–734.
10. Ryall J.G., Schertzer J.D., Lynch G.S. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogeronto 2008; 9: 213–228.
11. Rammos G, Tseke P, Ziakka S. Vitamin D, the renin-angiotensin system, and insulin resistance. Int Urol Nephrol 2008;40(2):419-426.
12. Liew J.Y., Sasha S.R., Ngu P.J., et al. Circulating vitamin D levels are associated with the presence and severity of coronary artery disease but not peripheral arterial disease in patients undergoing coronary angiography. Nutrit, Metab & Cardiovasc Dis 2015;25:274-279.
13. Gupta GK., Agrawal T., DelCore M. G., et al. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Experiment and Molec Pathol 2012; 93: 82–90
14. Fraga C., Blanco M., Vigo E., et al. Ontogenesis of the vitamin D receptor in rat heart. Histochem and Cell Biol 2002; 117: 547–550.
15. Wamberg L, Kampmann U, Stodkilde-Jorgensen H, Rejnmark L, Pedersen SB, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels e results from a randomized trial. Eur J Intern Med 2013; 24: 644-649.

Additional Files

Published

2016-06-30